CDKN1C
Beckwith-Wiedemann Syndrome Methylation-Specific MLPA
Key Information
Lab:
TAT:
21 days
Price:
$600
CPT Code(s):
81401
Test Code:
DBWM
Prenatal Samples Accepted
Beckwith-Wiedemann Syndrome Methylation-Specific MLPA
Beckwith-Wiedemann methylation-specific MLPA is a molecular test that detects methylation abnormalities or copy number variants and is used to confirm a diagnosis of Beckwith-Wiedemann syndrome. This condition is caused by alterations in methylation at two imprinting centers on chromosome 11p15.5. Additional testing may be necessary to determine the underlying genetic etiology.
Beckwith-Wiedemann syndrome
Clinical Information
BWS is the most common overgrowth syndrome characterized by large organs and body size. Macroglossia, ear lobe creases, helical creases, and omphalocele are common features as well. Patients with BWS are at an increased risk for embryonal tumors in childhood. These individuals typically have normal intelligence and attain a normal height and weight in adulthood.
Technical Information
Methylation Specific-Multiplex Ligation-dependent Probe Amplification (MS-MLPA) analysis is performed to determine if deletions, duplications, or methylation defects involving the imprinting center region 1 (ICR1) or imprinting center region 2 (ICR2) on 11p15.5 are present. MS-MLPA analysis allows for the determination of dosage for specific sequences of interest (Schouten et al. (2002) Nucleic Acids Research 30, e57) as well as for methylation status at several differentially methylated HhaI restriction sites. Genomic DNA is hybridized with probes that correspond to the CpG islands in the promoters of the H19 gene (ICR1) and the KCNQ1OT1 gene (ICR2) to determine dosage and methylation status of the DNA in that region.
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis is available if the familial mutations are known or there are clinical features identified via ultrasound suggestive of a diagnosis in the fetus. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen.
Prenatal diagnosis may be available if there are clinical features identified on ultrasound suggestive of Beckwith-Wiedemann syndrome. Amniotic fluid must be collected at a minimum of 16 weeks for MS-MLPA results to be informative. CVS samples are not accepted for this methylation-based test. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that requirements for receipt are met.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
